DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $141,493 | -49.1% | 10,268 | -38.9% | 0.02% | -42.9% |
| Q1 2024 | $277,817 | +89.0% | 16,817 | +67.1% | 0.04% | +20.7% |
| Q4 2023 | $146,978 | +438.1% | 10,067 | +352.2% | 0.03% | +262.5% |
| Q3 2023 | $27,313 | +137.3% | 2,226 | +130.9% | 0.01% | +100.0% |
| Q2 2023 | $11,510 | -13.6% | 964 | -3.2% | 0.00% | -20.0% |
| Q1 2023 | $13,317 | -17.2% | 996 | +33.3% | 0.01% | -16.7% |
| Q4 2022 | $16,075 | +14.8% | 747 | +8.6% | 0.01% | 0.0% |
| Q3 2022 | $14,000 | – | 688 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |